https://youtu.be/H_RititNE8U

Novavax beat Q2 earnings and revenue estimates, raises its 2026 adjusted revenue outlook, cuts expen

Novavax NASDAQ: NVAX reported second-quarter 2026 revenue of $57 million and a net loss of $53 milli

Novavax, Inc. (NVAX) Q2 2026 Earnings Call Transcript

Novavax (NVAX) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate

Here is how Novavax (NVAX) and Addus HomeCare (ADUS) have performed compared to their sector so far

Novavax raised its annual revenue forecast after beating quarterly expectations on Thursday, as the

Novavax (NASDAQ:NVAX) raises FY2026 sales outlook from $230.000 million-$270.000 million to $235.000

Reported total revenue of $57 million for the second quarter of 2026 and raised full-year 2026 Reven

GAITHERSBURG, Md., July 30, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that t

Novavax is significantly undervalued post-COVID, with a current enterprise value around $716 million

In the most recent trading session, Novavax (NVAX) closed at $7.37, indicating a -1.6% shift from th

Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhi

Novavax (NVAX) reached $7.88 at the closing of the latest trading day, reflecting a -4.02% change co

In the latest trading session, Novavax (NVAX) closed at $8.42, marking a -5.5% move from the previou

Novavax (NVAX) concluded the recent trading session at $9.35, signifying a -1.16% move from its prio

Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhi

In the closing of the recent trading day, Novavax (NVAX) stood at $8.9, denoting a -1.17% move from

RALEIGH, N.C., June 24, 2026 (GLOBE NEWSWIRE) -- Shah Capital, the largest shareholder of Novavax, t

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth ex

Novavax (NVAX) closed the most recent trading day at $9.13, moving 3.89% from the previous trading s

Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock is jumping again.

Moderna and Novavax stocks climb as investors digest new cases in the hantavirus outbreak.

Novavax shares rise after Q1 revenue beat; partnerships, credit facility, and technical levels shape

https://www.nytimes.com/2026/05/05/us/politics/fda-covid-vaccine-studies.html

Here's a look at the earnings calendar for the week ahead, including reports from Nvidia, Joby,

After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, wi

Retail investors are preparing for another busy week of earnings season with more than 1,600 compani

Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease

https://news.bloomberglaw.com/health-law-and-business/fda-names-vinay-prasad-as-new-head-of-vaccines

 On April 29, 2025, Novavax, Inc. (the "Company") entered into a collaboration and exclusive

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a